首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 140 毫秒
1.
端粒酶活性在哺乳动物细胞中的表达   总被引:4,自引:0,他引:4  
  相似文献   

2.
采用端粒酶重复序列扩增(telomeric repeat amplification protocol,TRAP)-银染法,对小鼠卵母细胞、体内受精胚胎及重构胚的各阶段端粒酶活性进行测定,对PCR产物的电泳条带进行灰度值分析,计算端粒酶总产品总量。结果表明:(1)体内受精胚胎及核移植重构胚各阶段的端粒酶活性随胚胎分裂呈上升趋势,囊胚期最高(P0.05);(2)体内受精胚胎的端粒酶活性高于体细胞核移植重构胚端粒酶活性。同时进行囊胚计数并测定单卵裂球相对端粒酶活性,结果表明:单卵裂球的端粒酶活性呈下降趋势,囊胚期端粒酶活性最低(P0.05)。以上结果说明小鼠卵母细胞及体细胞核移植重构胚端粒酶活性变化与细胞发育水平及细胞发育全能性有关。  相似文献   

3.
端粒位于真核染色体末端,是稳定染色体末端的重要元件。端粒酶(TER)是一种特殊的细胞核蛋白(RNP)反转录酶(RT),其核心酶包括蛋白亚基和RNA元件。在DNA复制过程中的端粒丢失可以被有活性的端粒酶补偿回来。哺乳动物端粒酶在发育中受调控,端粒的重编程可能是由于早期胚胎不同时期的端粒酶活性而造成的,因此,研究胚胎发育早期端粒和端粒酶重编程是非常重要的。本文对端粒和端粒酶的结构和功能,及其与哺乳动物早期胚胎发育的关系进行了综述.并在此基础上展望了端粒和端粒酶在克隆动物胚胎发育上的基础作用。  相似文献   

4.
肿瘤严重威胁着人类健康,近年来癌症患者不断增多且死亡率逐年上升。中药以其安全性高、价格低、毒副作用小等优点成为抗肿瘤的首选药物。研究证实,肿瘤细胞与端粒酶之间存在相互激发的关系,肿瘤细胞缺乏端粒酶调节机制,一旦端粒酶活性被激活,肿瘤细胞将会有无限增殖的能力。因此,抑制肿瘤细胞端粒酶活性可作为治疗肿瘤的方法之一。文章将从中药的几种有效成分及复方中药对肿瘤细胞端粒酶活性的抑制作用作一综述,探讨中药抑制肿瘤细胞端粒酶活性的研究进展及其应用前景。  相似文献   

5.
端粒、端粒酶具有特殊的结构和功能,因为其与肿瘤的密切关系已经引起人们的高度关注并成为当今分子生物学的研究热点之一。有资料证实,端粒酶的激活与恶性肿瘤的形成有密切关系^[1,2]。有些专家认为,端粒酶活性表达的多少可以做为恶性肿瘤发展程度的衡量指标,对于恶性肿瘤的早期诊断具有十分重要的意义。正因为如此,端粒酶活性的检测就显得尤为重要了。  相似文献   

6.
7.
端粒酶的活性与肿瘤的发生发展密切相关,因而抑制端粒酶活性研究必将成为肿瘤治疗的热点。本文综述了多糖类、生物碱类、皂苷类、黄酮类及其他中药活性成分抑制端粒酶活性的研究现状,并对其研究和应用前景作简要分析。  相似文献   

8.
端粒酶可修复细胞分裂过程中不断丢失的端粒序列,从而维持端粒的长度,在动物细胞寿命的调控中起着很重要的作用。因此,通过调控细胞中端粒酶的活性来影响体外培养细胞的发育状况,是目前提高体外培养效率的有效方法之一。文章对调节细胞中端粒酶活性的研究进展作一综述。  相似文献   

9.
为了解水牛卵母细胞和体外受精(IVF)胚胎早期发育过程中端粒酶的活性变化,本研究利用端粒重复序列扩增法(TRAP)进行了水牛未成熟卵母细胞,成熟卵母细胞和2~4细胞,8~16细胞,桑椹胚以及囊胚各阶段的早期胚胎端粒酶活性的测定。依据电泳条带在成像系统下的光密度值,计算端粒酶的相对活性(RTA)。结果发现,未成熟卵母细胞端粒酶活性比成熟卵母细胞高(P〈0.05),受精后2~4和8~16细胞胚胎端粒酶活性相对较低,桑椹胚端粒酶活性明显升高(P〈0.05),囊胚阶段达到最高水平。通过对水牛不同发育阶段胚胎细胞数计数及单细胞相对端粒酶活性的分析比较结果显示,卵母细胞的单细胞端粒酶活性最高,囊胚阶段的最低。单细胞端粒酶活性从未成熟卵母细胞到IVF囊胚阶段呈逐渐降低的趋势。这些结果表明,水牛卵母细胞及早期胚胎的端粒酶活性变化与其成熟、发育阻断及全能性的逐步降低有关。  相似文献   

10.
端粒位于真核生物染色体末端,它对维持染色体结构具有非常重要的意义。端粒酶能够以自身的RNA序列为模板反转录合成端粒的重复DNA序列,对端粒长度的维持以及哺乳动物的生长发育具有重要的作用。本文主要对端粒和端粒酶的结构和功能,以及它们在哺乳动物发育过程中的重要作用进行阐述。1端粒、端粒酶的结构和功能1.1端粒的结构和功能1.1.1端粒的结构:端粒位于真核生物染色体末端  相似文献   

11.
OBJECTIVE: To establish the diagnostic significance of the telomeric repeat amplification protocol (TRAP) assay in detecting feline malignancies. SAMPLE POPULATION: Solid tissue specimens collected from 33 client-owned cats undergoing diagnostic or therapeutic procedures at the University of Illinois Veterinary Medical Teaching Hospital between July 1997 and September 1999 and an additional 20 tissue samples were collected from 3 clinically normal control cats euthanatized at the conclusion of an unrelated study. PROCEDURE: The TRAP assay was used for detection of telomerase activity. Each result was compared to its respective histopathologic diagnosis. RESULTS: Twenty-nine of 31 malignant and 1 of 22 benign or normal tissue samples had telomerase activity, indicating 94% sensitivity and 95% specificity of the TRAP assay in our laboratory. CONCLUSIONS AND CLINICAL RELEVANCE: The diagnostic significance of telomerase activity has been demonstrated in humans and recently in dogs by our laboratory. We tested feline samples to determine whether similar patterns of telomerase activity exist. On the basis of our results, the TRAP assay may be clinically useful in providing a rapid diagnosis of malignancy in cats. The telomerase enzyme may also serve as a therapeutic target in feline tumors.  相似文献   

12.
本研究利用小干扰RNA技术探讨端粒酶催化亚单位对鸡马立克氏病MDCC-MSB1细胞端粒酶活性的影响。构建以chTERT基因为靶点的3个RNA干扰载体pRNAT-chTERT-siRNA,筛选并鉴定。利用脂质体转染MDCC-MSB1细胞48 h后,TRAP-PCR-ELISA法定量检测细胞端粒酶活性,并进一步筛选出最有效的小干扰RNA载体。结果显示:转染干扰载体的MDCC-MSB1细胞端粒酶活性逐渐降低,其中干扰载体pRNAT-chTERT-II转染后抑制效果最明显(0.01)。  相似文献   

13.
Telomerase has been studied extensively in human and murine tumors, but little is known about the role of telomerase in the tumor biology of other vertebrate species such as the chicken. We studied the telomerase activity of the lymphoblastoid cell line derived from lymphomas induced by Marek's disease virus (MDCC-MSB1) compared with another avian cell line (PA5) and peripheral blood lymphocytes (PBL) using the telomeric repeat amplification protocol (TRAP) Assay. Telomerase activity in MDCC-MSB1 was 4.5 times greater than in the PA5 cell line and normal avian lymphocytes. These results demonstrate for the first time that telomerase is more intense in one transformed cell line than in normal cells, suggesting a potential role for telomerase in carcinogenesis induced by an avian virus.  相似文献   

14.
15.
The proliferative capacity of mammalian cells is regulated by telomerase, an enzyme uniquely specialised for telomeric DNA synthesis. The critical role of telomerase activation in tumor progression and maintenance has been well established in studies of cancer and of oncogenic transformation in cell culture. Experimental data suggest that telomerase activation has an important role in normal somatic cells, and that failure to activate sufficient telomerase also promotes disease. Evidence regarding the role of telomerase in the pathogenesis of several viruses including human immunodeficiency virus has led to an increased interest in the role of telomerase activity in other virus infections. In this research we evaluated the telomerase modulating activity of Bovine herpesvirus 1 (BHV-1) in MDBK cells. MDBK cells were infected at different multiplicity of infection with BHV-1 Cooper strain and telomerase activity at different times post-infection was measured by the TRAP assay. Our data indicate that BHV-1 significantly up-regulates telomerase activity at 3 and 6h post-infection decreasing after the 24h post-infection. Our data, showed that the effect was mediated by an immediate-early or early viral gene, and use of the protein translation inhibitor cycloheximide confirmed that an immediate early gene is primarily responsible.  相似文献   

16.
17.
骨髓间充质干细胞(BMSC)具有多向分化的特性,但其生命周期有限,为进一步探讨端粒逆转录酶(TERT)对端粒酶活性的影响,本试验利用将外源性TERT导入间充质干细胞技术,构建重组表达载体pcDNA3.1-EGFP-TERT,将其转染BMSC,通过筛选及鉴定,结果显示成功构建了重组表达载体pcDNA3.1-EGFP-TERT.将TERT-BMSCs在体外进行传代培养及生长曲线的测定,利用PCR技术对其原有干细胞因子的表达情况进行了鉴定.结果显示,TERT-BMSC具有快速扩增的能力,细胞形态良好,且仍具有干细胞特性.本试验结果揭示了外源性TERT基因的表达能激活绵羊BMSC的端粒酶活性.  相似文献   

18.
Telomeres are specific structures present at the end of liner chromosomes. DNA polymerase can not synthesize the end of liner DNA and, as a result, the telomeres become progressively shortened by successive cell divisions. To overcome the end replication problem, telomerase adds new telomeric sequences to the end of chromosomal DNA. The enzyme activity is undetectable in most normal human adult somatic cells, in which shortening of the telomere is thought to limit the somatic-cell life span. In contrast to normal somatic cells, many human tumors possess telomerase activity. The present study looked at whether telomerase activity might serve as a marker for canine tumors. Telomerase activity was measured using the telomeric repeat amplification protocol assay. Normal dog somatic tissues showed little or no telomerase activity, while normal testis exhibited a high level of telomerase activity. We measured telomerase activity in tumor samples from 45 dogs; 21 mammary gland tumors, 16 tumors developed in the skin and oral cavity, 7 vascular tumors and 1 Sertoli cell tumor. Greater than 95% of the tumor samples contained telomerase activity (3-924 U/2 micrograms protein). The results obtained in this study indicated that telomerase should be a useful diagnostic marker for a variety of dog tumors, and it may serve as a target for antitumor chemotherapy.  相似文献   

19.
OBJECTIVES: To determine whether telomerase activity was present in lymph nodes, buffy coat, and serum samples from dogs with malignant lymphoma (ML) and in liver, lymph node, buffy coat, and serum samples from clinically normal dogs SAMPLE POPULATION: Tissue specimens and blood samples were obtained from 11 clinically normal adult dogs (age range, 1 to 4 years) and 14 client-owned dogs with ML. PROCEDURE: The telomere repeat amplification protocol assay was used to quantify telomerase activity in the tissues from clinically normal dogs and dogs with ML. RESULTS: Of 11 clinically normal dogs, 8 had lymph node samples, 5 had liver samples, and 1 had buffy coat samples with detectable telomerase activity. None of the serum samples from the clinically normal dogs had detectable telomerase activity. Of 14 dogs with ML, 9 had lymph node samples, 3 had buffy coat samples, and 1 had serum samples with measurable telomerase activity. CONCLUSIONS AND CLINICAL RELEVANCE: Telomerase activity was not specific to tumor cells and overlapped with that found in cells from clinically normal dogs. Telomerase activity in neoplastic lymph nodes was not substantially different from that found in lymph nodes from clinically normal dogs. The determination of telomerase activity cannot be used as a sole diagnostic test for cancer. Therapeutic modalities directed toward the telomerase enzyme may not be feasible in dogs, because somatic tissues from clinically normal dogs possess variable amounts of telomerase activity.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号